Rexall's American owner puts pharmacy up for sale as it rethinks Canadian footprint, sources say
McKesson, a distribution giant in the pharmaceutical industry, struggled with Rexall’s profit margins early in its ownership despite making a major splash with its $2.9-billion acquisition in 2016